Clinical Trial Update: Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the bioequivalence of Synflutide HFA Inhaler versus Seretide Evohaler in healthy volunteers with charcoal blocking to assess system…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Seretide Evohaler (salmeterol/fluticasone)
• Synflutide HFA Inhaler

Snippet

Sponsor: Intech Biopharm Ltd. | Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED